You are here

Article info

Article menu
Download PDFPDF
Commentary
Telomere length and pancreatic cancer risk: breaking down the evidence

Authors

  1. Correspondence to Dr Eric J Duell, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), Avda Gran Via 199-203, L'Hospitalet de Llobregat, Barcelona 08908, Spain; eduell{at}iconcologia.net
View Full Text

Citation

Duell EJ
Telomere length and pancreatic cancer risk: breaking down the evidence
Gut 2017;66:1.

Publication history

  • Accepted November 14, 2016
  • First published December 5, 2016.
Online issue publication 
June 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/